RSS Feeds
Search

Companies

Companies

Displaying 1..10 of 55 - per page Next page
Order by
Profiled on pharmalicensing.com Inven2 AS
Inven2 AS identifies, protects and commercialises inventions and discoveries of the University of Oslo, Oslo University Hospital and other health enterprises in the south-east of Norway. More
Profiled on pharmalicensing.com CrystecPharma
CrystecPharma applies the latest supercritical fluid (SCF) technologies to improve the design and performance of medicines More
Profiled on pharmalicensing.com National Jewish Health
The mission of National Jewish Health is to heal, to discover and to educate as a preeminent healthcare institution. More
Decision Resources Inc.
The worldwide leader in market research publications, advisory services and consulting More
Palau Pharma
Palau Pharma is a product-driven biopharmaceutical company focused on the discovery and development of new medicines for the treatment of inflammatory and autoimmune diseases. More
BiotechEast Co., Ltd. (Technology Partner)
BiotechEast is a one-stop, full-service marketing consultancy for those looking to take advantage of the dynamic opportunities in Taiwan's burgeoning life science industry. More
Aptalis Pharmaceutical Technologies
Worldwide Leader in Drug Delivery/Specialty Pharmaceuticals More
NorthShore University HealthSystem Research Institute
NorthShore University HealthSystem Research Institute More
LG Life Sciences
Pharmaceuticals Division, Agrochemicals Division, Animal Health Division More
Kowa Company Limited
The primary therapeutic areas being focused upon are cardiovascular and related conditions (e.g. diabetes), anti-inflammatory conditions (R.A), dermatology and ophthalmology. More
Displaying 1..10 of 55 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes
Nov 2010 - 5 pages - $500
Acute Coronary Syndromes Therapy Area Pipeline Report
Nov 2010 - 329 pages - $1,495
Acute Coronary Syndromes - Pipeline Review, Q1 2011
Feb 2011 - 62 pages - $500
Epidemiology: Acute Coronary Syndrome - Now affecting primarily the oldest populations
Jul 2011 - 46 pages - $3,800
Acute Coronary Syndrome - Pipeline Review, H2 2011
Sep 2011 - 106 pages - $500
Acute Coronary Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 49 pages - $2,000
Innovations in Cardiovascular Disease Management
May 2007 - 183 pages - $2,875
The Future of Cardiovascular Diagnostics: Impact of technological advances on growth opportunities and future market outlook
Mar 2010 - 180 pages - $3,835
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Aug 2008 - 120 pages - $1,040
The Medicines Company: Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile
Jun 2008 - 49 pages - $495
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us